PSNLPersonalis, Inc.

1. Oct 6, 2026As previously disclosed, on July 20, 2026, Personalis, Inc., a Delaware corporation (“Personalis” or the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Tempus AI, Inc., a Nevada corporation (“Tempus” or “Parent”), Aviary Development, Inc., a Delaware corporation and a direct …Other event · Form 8-K
2. Aug 20, 2026On August 20, 2026, Personalis, Inc. received a new task order under its contract with the U.S. Department of Veterans Affairs (VA) for the VA's Million Veteran Program (VA MVP)Other event · Form 8-K
3. Aug 4, 2026Personalis Reports Second Quarter Results and Recent Highlights.Earnings release · press release
4. Jul 20, 2026Agreement and Plan of Merger On July 20, 2026, Personalis, Inc., a Delaware corporation (“Personalis” or the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Tempus AI, Inc., a Nevada corporation (“Tempus” or “Parent”), Aviary Development, Inc., a Delaware …Material agreement entered · Form 8-K
5. Jul 20, 2026Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled.Earnings release · press release
6. May 20, 2026On May19, 2026, the Centers for Medicare & Medicaid Services Molecular Diagnostics Program expanded Medicare coverage for Personalis, Inc.’s ultrasensitive NeXT Personal ® test to include monitoring treatment response to neoadjuvant therapy (NAT) in patients diagnosed with Stage II-III Triple-Negative Breast Cancer …Other event · Form 8-K
7. May 13, 2026On May12, 2026, the Centers for Medicare & Medicaid Services Molecular Diagnostics Program expanded Medicare coverage for our ultrasensitive NeXT Personal ® test to include immunotherapy monitoring for patients with late-stage solid tumors.Other event · Form 8-K
8. May 7, 2026Personalis Reports First Quarter Results and Recent Highlights.Earnings release · press release
9. Mar 17, 2026On March 13, 2026, the board of directors (the “Board”) of Personalis, Inc. (the “Company”), based in part on the recommendation of Christopher Hall, the Company’s Chief Executive Officer, appointed Richard Chen as the Company’s President, in addition to his roles as the Company’s Executive Vice President, R&D, and …Director or officer change · Form 8-K
10. Feb 26, 2026Personalis Reports Fourth Quarter and Full Year 2025 Results and Recent Highlights.Earnings release · press release
11. Jan 8, 2026Personalis Reports Select Preliminary Fourth Quarter and Full Year 2025 Results and Recent Highlights.Earnings release · press release

Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.